NEW YORK (TheStreet) -- CHANGE IN RATINGS
Acadia Healthcare (ACHC) was initiated with a buy rating at Cantor Fitzgerald. $35 price target. Company should benefit from a better regulatory environment and can deliver above-average growth, Cantor Fitzgerald said.
Affiliated Managers (AMG) was upgraded at Goldman to buy. Company can generate solid organic growth, Goldman said. $170 price target.
Carnival (CCL) was downgraded to hold at TheStreet Ratings.Coach (COH) was upgraded to buy from neutral at Citigroup. The stock has transitioned to a value stock and the risk is partially priced in, Citi said. Price target remains $56. Cash America International (CSH) was downgraded at Sterne Agee to neutral. Valuation is full. The stock is up 33% year-to-date and within 4% of Stern Agee's new price target of $55. Discover (DFS) was upgraded at FBR Capital Markets to outperform from market perform. $48 price target. Estimates also boosted, given higher receivables and interest income, as well as lower credit costs, FBR Capital Markets said. Dril-Quip (DRQ) was initiated with a buy rating at Lazard Capital Markets. $105 price target. Company can deliver 25% annual earnings growth over the next two years. First Cash Financial Services (FCFS) was downgraded at Sterne Agee to neutral. The call is based on a fair valuation, Sterne Agee said. Fortress (FIG) was upgraded at Goldman Sachs to buy. Legacy funds have recovered well, Goldman said. Freescale (FSL) was downgraded at Bernstein Research to market perform from outperform. Valuation call, based on an $18 price target, Bernstein said. Genesco (GCO) was upgraded at Piper Jaffray to overweight from neutral. $73 price target. Company has strong long-term earnings potential, Piper Jaffray said. Hasbro (HAS) was downgraded at Keybanc to hold from buy. The stock has doubled the market year-to-date and the company lacks near-term catalysts, Keybanc said. Oracle (ORCL) was upgraded at Canaccord Genuity to buy from hold. $42 price target. Stock sets up well for a 10%-20% run, Canaccord Genuity said. Stericycle (SRCL) was initiated with a buy rating at Goldman Sachs. $115 price target. Company can continue to gain domestic market share and also grow outside of the U.S., Goldman said.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV